Bakri Elsheikh

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge et al. · The Lancet Neurology · 2023 · 250 citations

Medicine, Pharmacotherapy, Pain Management +2

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban et al. · The Lancet Neurology · 2019 · 223 citations · Full text

Medicine, Endocrinology, Surgery +5

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis

James F. Howard, Richard J. Nowak, Gil I. Wolfe et al. · JAMA Neurology · 2020 · 193 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy

Kathryn J. Swoboda, Charles Scott, Sandra P. Reyna et al. · PLoS ONE · 2009 · 177 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis

Mamatha Pasnoor, Jianghua He, Ted M. Burns et al. · Neurology · 2016 · 131 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14